Large gap with delayed quotes
|
Last quote
05/29/2026
-
17:31:09
|
Bid
05/29/2026 -
17:40:00
|
Bid Volume |
Ask
05/29/2026 -
17:40:00
|
Ask Volume |
|---|---|---|---|---|
|
27.00
+0.40
(
+1.50% )
|
26.60
|
10 |
27.50
|
50 |
Analysis date: 29.05.2026
Global Evaluation
Negativ
Negativ
The stock is classified in the negative zone since 01.05.2026.
Interest
None
None
No stars since 19.05.2026.
Earnings Rev Trend
Negative
Negative
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 21.04.2026 at a price of 29.90.
Evaluation
Strongly overvalued
Strongly overvalued
Based on its growth potential and our own criteria, we believe the share price is currently overvalued.
MT Tech Trend
Neutral
Neutral
The stock is currently trading close to its dividend-adjusted forty day moving average (changes between +1.75% and -1.75% are considered neutral). Prior to this, the stock traded below its moving average since 12.05.2026.
4wk Rel Perf
-12.90%
-12.90%
The four-week dividend-adjusted underperformance versus STOXX600 is 12.90%.
Sensibility
High
High
The stock has been on the high-sensitivity level since 21.04.2026.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -1.28%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 4.23%.
Mkt Cap in $bn
0.20
0.20
With a market capitalization <$2bn, BIOVERSYS AG is considered a small-cap stock.
G/PE Ratio
-0.82
-0.82
A negative ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) indicates that either the forecasted growth is decelerating (negative annualized growth estimate) or the financial analysts are expecting a loss (negative estimated PE).
LT P/E
-6.17
-6.17
The estimated PE is negative: the financial analysts' earnings estimates forecast a loss.
LT Growth
-5.07%
-5.07%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
5
5
Over the last seven weeks, an average of 5 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
-7
-7
For 1% of index variation, the stock varies on average by -0.07%.
Correlation
-0.02
-0.02
Stock movements are strongly independent of index variations, with an even divergent trend.
Value at Risk
10.85
10.85
The value at risk is estimated at CHF 10.85. The risk is therefore 40.20%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
21.04.2026
21.04.2026